EichorEICHOR
Study identifier: NCT03888105 Synced from ClinicalTrials.gov · August 02, 2026
● Active Not Recruiting

A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies

Condition: B-cell Non-Hodgkin Lymphoma (B-NHL)  ·  Sponsor: Regeneron Pharmaceuticals

PhasePhase 2
Planned participants515
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is researching an investigational drug, odronextamab, in adult patients B-cell non-Hodgkin's lymphoma (B-NHL). The main purpose of this study is to assess the effectiveness of odronextamab in destroying cancer cells and to learn more about the safety of odronextamab. The study is looking at several other research questions, including: * To see if odronextamab works to destroy cancer cells * Side effects that may be experienced by people taking odronextamab * How odronextamab works in the body * How much odronextamab is present in the blood

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (119)

Rush University Medical CenterChicago, Illinois, United States
University of IowaIowa City, Iowa, United States
Norton Cancer InstituteLouisville, Kentucky, United States
Tufts Medical CenterBoston, Massachusetts, United States
Beth Israel Deaconess Medical CenterBoston, Massachusetts, United States
Mayo Clinic - RochesterRochester, Minnesota, United States
John Theurer Cancer Center at Hackensack UMCHackensack, New Jersey, United States
Weill Cornell Medical College New York Presbyterian HospitalNew York, New York, United States
Stony Brook University HospitalStony Brook, New York, United States
Wake Forest Baptist Medical CenterWinston-Salem, North Carolina, United States
Cleveland Clinic FoundationCleveland, Ohio, United States
Stephenson Cancer CenterOklahoma City, Oklahoma, United States

+ 107 more locations — full list on the registry record.

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →